Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04686422 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of a Bulk Fill Resin Composite

A NA study of Dental Caries and Unsatisfactory or Defective Restoration of Tooth, sponsored by Ivoclar Vivadent.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT04686422 is a NA study of Dental Caries and Unsatisfactory or Defective Restoration of Tooth that has completed, run by Ivoclar Vivadent. The registered enrollment target is 39 participants, below the 721-participant average among 30 other Dental Caries trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04686422, a NA study of Dental Caries and Unsatisfactory or Defective Restoration of Tooth, has completed, sponsored by Ivoclar Vivadent.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to measure the clinical outcomes of Tetric PowerFill Class I and II restorations cured in 3 seconds with the Bluephase PowerCure curing unit.

Interventions

  • DEVICE Tetric PowerFill

Study Locations (1)

Alabama

  • UAB School of Dentistry - Birmingham

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2017-12-01
Est. Completion 2021-06-30
Phase NA

Sponsor

Ivoclar Vivadent

4 total trials

What the Registry Record Tells You About NCT04686422

The ClinicalTrials.gov registry entry for NCT04686422 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 721-participant average among 30 other Dental Caries trials with a reported enrollment target (95% lower). The listed sponsor is Ivoclar Vivadent, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dental Caries appearing as the primary indexed condition, and to 1 intervention - of which Tetric PowerFill is the first listed.

NCT04686422 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04686422 about?

NCT04686422 is a clinical study titled "Clinical Evaluation of a Bulk Fill Resin Composite". The purpose of this clinical trial is to measure the clinical outcomes of Tetric PowerFill Class I and II restorations cured in 3 seconds with the Bluephase PowerCure curing unit.

What is the current status of trial NCT04686422?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-12-01. Estimated completion is 2021-06-30.

What conditions does trial NCT04686422 study?

This clinical trial studies the following conditions: Dental Caries, Unsatisfactory or Defective Restoration of Tooth.

What interventions are being tested in trial NCT04686422?

The interventions under investigation include: Tetric PowerFill (DEVICE).

Who is sponsoring clinical trial NCT04686422?

This trial is sponsored by Ivoclar Vivadent, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04686422 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.